PPARG and fatty liver disease: Finally, among the DEGs, some are also key regulators of hepatic lipid metabolism (e.g., PIK3R1, PPARG, S100A11, Figure 2E,F), suggesting that alterations in TIA1 expression/activity also contribute to fatty liver disease development.